Pexacerfont

CAS : 459856-18-9

Ref. 3D-FP170137

Informations sur le produit

• Nom: Pexacerfont
• Synonymes: BMS 562086, 8-(6-Methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]pyrazolo[1,5-a]-1,3,5-triazin-4-amine, Pyrazolo[1,5-a]-1,3,5-triazin-4-amine, 8-(6-methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]-

Description

Pexacerfont is an experimental drug that has been used as a model to study the pharmacokinetic properties of drugs. It has been shown to be an antagonist of gamma-aminobutyric acid (GABA), and this may be due to its ability to inhibit the binding of GABA to its receptors. Pexacerfont has also been shown to have pharmacological effects in humans, such as improving locomotor activity and reducing symptoms of anxiety. Pexacerfont is not toxic in animal studies, but it is unclear if these results are clinically relevant.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 340.42 g/mol
• Formule: C₁₈H₂₄N₆O
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder
• InChI: InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1
• Code InChI: InChIKey=LBWQSAZEYIZZCE-SNVBAGLBSA-N
• SMILES: CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12